Purchase Order N3239821P0010
- Not listed
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian federal agency, to Illumina, Inc. for the provision of ILLUMINA SUPPLIES. The contract has a ceiling value of $302,813.03 and a period of performance through March 19, 2025. No set-aside was used. Illumina is an established provider of sequencing and genomic analysis instruments and reagents, having supported research and diagnostic needs across various federal...
- This is a firm fixed-price federal contract awarded by the Southeast Area of the U.S. Department of [federal agency] to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract, valued at $16,285.00, is for a service agreement to provide maintenance and support for an Illumina MiSeq sequencing system. The contract was awarded on a sole-source basis, with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents,...
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Human Genome Research Institute to Illumina, Inc., a manufacturer of genetic sequencing systems and analytical instruments. The $149,817.44 contract does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing instruments,...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $130,484.52 contract is for the provision of Illumina sequencing instruments, reagents, and consumables to support genomic research and diagnostics applications. This appears to be part of a larger Indefinite Delivery Contract worth up to $3.3...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis solutions. The $129,148.82 contract provides Illumina sequencing systems, reagents, consumables, and associated services to support genomic research and diagnostics at the National Institute of Environmental Health Sciences. This award is not set-aside and is part of a larger Indefinite...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis solutions, for the provision of laboratory supplies and reagent kits. The contract has a potential value of $157,326.62 and a completion date of June 13, 2023. The contract does not have a set-aside designation. Illumina has previously provided a range...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $91,872.00 contract is for maintenance and repair services for Illumina laboratory equipment used by the agency, with a completion date of June 10, 2027. Illumina has provided sequencing systems and associated products and services to support genomic...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract provides for an ISEQ 100 ADVANCE EXCHANGE SUPPORT PLAN for a ceiling value of $8,401.00 over a term ending on April 18, 2025. Illumina is a for-profit organization and established manufacturer of goods that has previously been awarded federal contracts and subcontracts to provide...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This is a firm fixed price contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc. for the maintenance and repair of instruments and laboratory equipment. The $80,972.56 contract has an August 2022 completion date and does not utilize any set-aside provisions. Illumina is a for-profit manufacturer that has previously held prime contracts and subcontracts with various federal agencies, including the NIH, CDC, USDA, and VA, to provide genomic sequencing instruments, reagents, and bioinformatics services. While this award does not appear to be associated with a larger contract vehicle, Illumina holds an Indefinite Delivery Contract worth up to $3.3 million with the Department of the Navy Bureau of Medicine and Surgery to support nucleic acid sequencing needs at the Naval Medical Research Center.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $81.0k | 8/11/21 |